Cooper Cos. (COO) News
Filter COO News Items
COO News Results
|Loading, please wait...|
COO News Highlights
- COO's 30 day story count now stands at 14.
- Over the past 17 days, the trend for COO's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- AL, CELL and CVI are the most mentioned tickers in articles about COO.
Latest COO News From Around the Web
Below are the latest news stories about COOPER COMPANIES INC that investors may wish to consider to help them evaluate COO as an investment opportunity.
Delving into the financial growth, competitive edges, and market leadership of The Cooper Companies Inc (COO)
SAN RAMON, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that it will transfer the listing of its common stock from the New York Stock Exchange (“NYSE”) to the Nasdaq Stock Market (“Nasdaq”). Cooper expects to begin trading as a Nasdaq-listed company at market open on September 26, 2023, and will continue to trade under the symbol “COO.” “We are excited to join many of the world’s largest and most innovative companies on Nasdaq,” said Al White, President
SAN RAMON, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Baird Healthcare Conference on Wednesday, September 13, 2023. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled to begin at 1:25 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be a
CooperSurgical, a global leader in fertility and women's health, announced that Cord Blood Registry® (CBR®) will have a key role in the upcoming Cord Blood Connect meeting from September 8th – 11th, which is the annual meeting of the Cord Blood Association. The Cord Blood Association is an international nonprofit organization that promotes both public and family newborn stem cell preservation and accelerates the use of cord blood and birthing tissues to benefit patients and advance medicine.
Key Insights Cooper Companies' estimated fair value is US$430 based on 2 Stage Free Cash Flow to Equity Cooper...
A deep dive into The Cooper Companies Inc (COO)'s intrinsic value and its potential for value investors
The Cooper Companies, Inc. (NYSE:COO) Q3 2023 Earnings Call Transcript August 30, 2023 The Cooper Companies, Inc. reports earnings inline with expectations. Reported EPS is $3.35 EPS, expectations were $3.35. Operator: Good afternoon. My name is Krista, and I’ll be your conference operator today. At this time, I would like to welcome everyone to the […]
Cooper Companies' (COO) third-quarter fiscal 2023 revenues reflect a solid segmental performance with improved adjusted earnings amid rising expenses.
Q3 2023 Cooper Companies Inc Earnings Call
Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended July 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.